Adlai Nortye (ANL) Short term Debt (2022 - 2025)

Adlai Nortye (ANL) reported Short term Debt of $24.6 million for Q4 2025, down 6.64% year-over-year from $26.3 million in Q4 2024, and down 44.2% on a QoQ basis from $44.1 million in Q2 2025.

Adlai Nortye (ANL) has 4 years of Short term Debt data on file, last reported at $24.6 million in Q4 2025.

  • Quarterly Short term Debt fell 6.64% year-over-year to $24.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $24.6 million (down 6.64% YoY) and the FY2025 annual result came in at $24.6 million, down 6.64% from the prior year.
  • Short term Debt eased to $24.6 million in Q4 2025 per ANL's latest filing, from $44.1 million in the prior quarter.
  • Across five years, Short term Debt topped out at $44.1 million in Q2 2025 and bottomed at $4.3 million in Q4 2022.
  • The 4-year median for Short term Debt is $28.3 million (2023), against an average of $28.1 million.
  • The widest annual swing landed in 2023, when Short term Debt jumped 604.83%; it then dropped 13.27% in 2024.
  • Tracing ANL's Short term Debt over 4 years: stood at $4.3 million in 2022, then jumped by 604.83% to $30.4 million in 2023, then slipped by 13.27% to $26.3 million in 2024, then retreated by 6.64% to $24.6 million in 2025.
  • Per Business Quant, the three latest ANL Short term Debt figures stand at $24.6 million (Q4 2025), $44.1 million (Q2 2025), and $26.3 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn -
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn
4 Nanobiotix 2,282.79 Bn 2,282.72 Bn -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn -
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn
8 Evaxion A 65.44 Bn 65.42 Bn -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn
10 Adlai Nortye 23,840.00 -8.03 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 24.58 Mn
Jun 30, 2025 44.05 Mn
Dec 31, 2024 26.33 Mn
Jun 30, 2024 38.89 Mn
Dec 31, 2023 30.36 Mn
Dec 31, 2022 4.31 Mn